Adendra Therapeutics

London, United Kingdom

Adendra Therapeutics wants to use new insights into dendritic cell biology to develop a novel type of immunotherapy.

$53.0M raised

Dec 2021

Series A

Biopharma Biotechnology Genetics Health Care

Top Investors

Apple Tree Partners

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Adendra Therapeutics

How much funding has Adendra Therapeutics raised?

Adendra Therapeutics has raised $53.0M in total funding. The most recent round was Series A. The last funding was announced in December 2021.

Who are Adendra Therapeutics's investors?

Adendra Therapeutics's investors include Apple Tree Partners.

Where is Adendra Therapeutics headquartered?

Adendra Therapeutics is headquartered in London, United Kingdom.

What does Adendra Therapeutics do?

Adendra Therapeutics wants to use new insights into dendritic cell biology to develop a novel type of immunotherapy.

What stage is Adendra Therapeutics at?

Adendra Therapeutics is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated December 7, 2021.

MLA

"Adendra Therapeutics — Funding & Investors." VCBacked, December 7, 2021, https://www.vcbacked.co/company/adendra-therapeutics. Accessed July 2, 2026.

APA

VCBacked. (2021). Adendra Therapeutics — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/adendra-therapeutics

Wikipedia (cite web)

{{cite web |title=Adendra Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/adendra-therapeutics |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated December 7, 2021.